Media coverage about UnitedHealth Group (NYSE:UNH) has trended somewhat positive on Thursday, according to Accern Sentiment. The research firm identifies negative and positive news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. UnitedHealth Group earned a news impact score of 0.23 on Accern’s scale. Accern also assigned media stories about the healthcare conglomerate an impact score of 45.9894215538371 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
These are some of the news articles that may have effected Accern’s analysis:
- Unitedhealth Group Inc (UNH) Vice Chmn, UHG and CEO, Optum Larry C Renfro Sold $5 million of Shares – Nasdaq (nasdaq.com)
- GOP Passes Landmark Tax Bill: Best & Worst for Stocks (finance.yahoo.com)
- UnitedHealth Group Schedules Fourth Quarter and Full Year Earnings Release and Conference Call for January 16, 2018 (markets.financialcontent.com)
- Humana-Kindred Deal Keeps Shakeout Alive in Healthcare Space (finance.yahoo.com)
UNH has been the topic of a number of recent research reports. ValuEngine raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Friday, September 1st. Cantor Fitzgerald lifted their target price on UnitedHealth Group to $225.00 and gave the company an “overweight” rating in a research report on Wednesday, October 18th. Credit Suisse Group initiated coverage on UnitedHealth Group in a research report on Thursday, November 2nd. They issued an “outperform” rating and a $233.00 target price on the stock. Wells Fargo & Company reaffirmed an “outperform” rating and issued a $245.00 target price (up previously from $230.00) on shares of UnitedHealth Group in a research report on Wednesday, November 29th. Finally, Royal Bank of Canada lifted their target price on UnitedHealth Group to $244.00 and gave the company an “outperform” rating in a research report on Wednesday, November 29th. They noted that the move was a valuation call. Three research analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $224.56.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The company had revenue of $50.32 billion during the quarter, compared to analysts’ expectations of $50.38 billion. During the same quarter in the previous year, the company posted $2.17 earnings per share. The business’s revenue was up 8.7% on a year-over-year basis. analysts forecast that UnitedHealth Group will post 9.99 earnings per share for the current year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, December 12th. Investors of record on Friday, December 1st were paid a $0.75 dividend. This represents a $3.00 annualized dividend and a dividend yield of 1.35%. The ex-dividend date of this dividend was Thursday, November 30th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 33.26%.
In related news, Director Kenneth Irwin Shine sold 457 shares of the business’s stock in a transaction that occurred on Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total value of $96,440.71. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction that occurred on Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total value of $1,250,536.00. Following the completion of the sale, the director now owns 61,137 shares of the company’s stock, valued at $13,652,503.47. The disclosure for this sale can be found here. Over the last quarter, insiders sold 34,630 shares of company stock valued at $7,669,416. 0.89% of the stock is currently owned by corporate insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.